Project Grant R01DK144719
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $200,660 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Albert Einstein College of Medicine. The grant will fund the development and testing of a mobile health application for a digital mind-body intervention (DMBI) targeted at improving psychological distress and quality-of-life among Black and Hispanic patients with inflammatory bowel disease...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $3,096,280.00 to conduct research on the effects of internet-based cognitive behavioral therapy for depression (ICBT-D) in people with HIV (PWH). The key objectives are to: 1) Determine the effects of ICBT-D on insulin resistance in depressed PWH on antiretroviral therapy; 2) Examine...
- This Project Grant award from the National Institute of Nursing Research (NINR), under the Federal Grant Program titled "Nursing Research" (CFDA 93.361), provides $441,375 to Children's Hospital Medical Center in Cincinnati, OH to evaluate the SMART IBD app digital therapeutic tool for pediatric inflammatory bowel disease (IBD). The project aims to address the significant issue of poor disease self-management in pediatric IBD, with up to 88% of adolescents demonstrating nonadherence to...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $847,498 to New York University (NYU) to develop and test an AI-driven clinical decision support system (CDS) and chatbot for managing patients on incretin mimetic medications (IMMs) for obesity treatment. The goal is to increase patient adherence and reduce the burden on healthcare...
- This Project Grant award of $234,000 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research at the University of Colorado-Denver to investigate the role of the Aiolos transcriptional regulator in the pathogenesis of inflammatory bowel disease. The researchers aim to utilize CRISPR-Cas9 genome editing to examine how Aiolos regulates T cell...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $762,556 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Aurora Health Care, Inc. The award supports the development of a novel, semi-automated self-monitoring feedback system for health promotion in community settings. The project aims to optimize the efficacy of feedback messages related to dietary intake, physical activity, and weight...
- This Project Grant award of $554,874 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) supports research at Northern Illinois University to investigate the role of the gut-brain-microbiota axis in the development of inflammatory bowel disease (IBD) induced by long-term stress. The key objectives are to determine how prolonged social isolation and IBD induction affect the gut microbiome of...
- This $172,232 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports research to understand the causes of inflammatory bowel disease (IBD) therapy failure. The principal investigator, Dr. Simon M. Gray, a gastroenterologist at the University of North Carolina at Chapel Hill, will leverage a pre-clinical mouse model to study the immunologic and...
- The federal Project Grant award of $762,489 from the National Center for Complementary and Integrative Health (NCCIH), under the CFDA program "Research and Training in Complementary and Integrative Health", aims to evaluate the feasibility, acceptability, adherence, safety, and potential implementation barriers of home-based transcutaneous auricular vagus nerve stimulation (TAVNS) intervention in young adults (18-29 years old) diagnosed with irritable bowel syndrome (IBS). The study,...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $769,155 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the Regents of the University of Michigan to conduct a two-arm, hybrid type 1 effectiveness-implementation trial. The objective is to compare an adapted diabetes self-management support (DSMS) intervention delivered virtually against enhanced usual care for adults with type 2 diabetes and...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $349,160 Project Grant to Cedars-Sinai Medical Center to conduct a pilot randomized controlled trial assessing the feasibility and clinical impact of an 8-week home-based virtual reality (VR) and artificial intelligence (AI)-enhanced cognitive behavioral therapy (CBT) program for patients with inflammatory bowel disease (IBD) and anxiety. The study aims to evaluate the program's ability to improve anxiety, health-related quality of life, and potentially inflammatory biomarkers in IBD patients. This pilot project will be conducted at Cedars-Sinai and the University of Chicago, with the award spanning the period from September 2025 to June 2028.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $349.2k | 9/10/25 |